Search

Your search keyword '"Whitaker, Jennifer A."' showing total 1,011 results

Search Constraints

Start Over You searched for: Author "Whitaker, Jennifer A." Remove constraint Author: "Whitaker, Jennifer A." Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
1,011 results on '"Whitaker, Jennifer A."'

Search Results

1. Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.

2. Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.

3. Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.

4. Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases

5. Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case.

6. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

7. Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial

9. Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial

11. Risk of COVID-19 after natural infection or vaccination

12. 135 A Year Later: A multi-institutional QI project to enhance leadership conversations about retention

13. Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo

14. 2395. An Interim Report of the Safety, Reactogenicity, and Immunogenicity of a Self-amplifying mRNA (samRNA) COVID-19 Vaccine GRT-R910 as a Booster in Healthy Adults

16. Risk of COVID-19 after natural infection or vaccination

17. Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive COVID-19 Treatment Trial (ACTT) as a Test Case

18. Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial

19. SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses

20. Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant

22. High School Band Students' and Directors' Perceptions of Verbal and Nonverbal Teaching Behaviors

23. Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant

25. Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis

27. Immunogenicity of a Recombinant Herpes Zoster Vaccine in Patients with Chronic Lymphocytic Leukemia

28. Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis.

33. A Complicated Case of Group B Streptococcus Empyema Necessitans

34. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers

38. Metabolic Phenotypes of Response to Vaccination in Humans

41. Mind the Gap: Knowledge, Attitudes, and Practices of Internal Medicine Residents Toward Adult Immunizations

42. Severe destructive nasopharyngeal granulomatosis with polyangiitis with superimposed skull base Pseudomonas aeruginosa osteomyelitis.

46. Don't Betray The Women

Catalog

Books, media, physical & digital resources